Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Titan Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524717NSE Symbol: Not ListedP/E(TTM):40.56
ISIN Demat:INE150C01011Div & Yield %:0.2EPS(TTM):24.92
Book Value(Rs):189.4317315Market Cap ( Cr.):835.25Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 156.45164.07144.00123.55122.4669.48
Excise Duty0.000.000.000.000.000.00
Net Sales156.45164.07144.00123.55122.4669.48
Other Income 3.911.751.940.940.751.02
Stock Adjustments 2.855.290.930.172.230.65
Total Income163.21171.11146.87124.66125.4471.15
EXPENDITURE :      
Raw Materials 79.3485.3374.6161.6457.5836.75
Power & Fuel Cost9.8310.248.986.674.103.53
Employee Cost 26.3823.7118.2114.2411.089.07
Other Manufacturing Expenses 3.764.103.442.963.771.36
Selling and Administration Expenses 13.4410.759.216.425.668.40
Miscellaneous Expenses 1.120.950.960.521.050.15
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure133.88135.07115.4292.4683.2359.25
Operating Profit29.3436.0331.4732.2142.2011.90
Interest 0.801.170.750.871.331.91
Gross Profit28.5434.8630.7231.3440.879.99
Depreciation4.173.332.602.372.101.75
Profit Before Tax24.3731.5328.1228.9738.778.24
Tax5.977.767.187.359.861.85
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.120.11-0.09-0.070.130.19
Reported Net Profit18.2723.6621.0221.6828.776.20
Extraordinary Items 0.000.000.000.00-0.240.46
Adjusted Net Profit18.2723.6621.0221.6829.015.74
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward111.1889.0069.2248.7720.8314.62
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1.651.491.241.240.830.00
P & L Balance carried down127.80111.1889.0069.2248.7720.83
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %20.0020.0018.0015.0015.0010.00
Earnings Per Share-Unit Curr22.1128.6425.4426.2434.827.50
Earnings Per Share(Adj)-Unit Curr22.1128.6425.4426.2434.827.50
Book Value-Unit Curr175.63155.43128.38104.3679.6545.76